Risk, returns & timeframes illustration
1 min read
April 5, 2022
by

Athleisure delivers on bliss 律

Stretchy pants got you through the WFH highs ‘n’ lows? 🧘 Seems you’re not the only one, with Nike and Lululemon reporting strong results in their latest earnings. 📈 See how Lululemon’s bringing the bliss.
1 min read
April 5, 2022
by

Athleisure delivers on bliss 律

Stretchy pants got you through the WFH highs ‘n’ lows? 🧘 Seems you’re not the only one, with Nike and Lululemon reporting strong results in their latest earnings. 📈 See how Lululemon’s bringing the bliss.
1 min read
April 5, 2022
by

Athleisure delivers on bliss 律

Stretchy pants got you through the WFH highs ‘n’ lows? 🧘 Seems you’re not the only one, with Nike and Lululemon reporting strong results in their latest earnings. 📈 See how Lululemon’s bringing the bliss.
Table of contents
Getting Started Investing course
Free Getting Started Course
Take your first, or next, step to becoming a confident investor with Hatch's free online course – just 10 minutes a day, for 10 days.

The athleisure market is expected to stretch to US$257.1 billion in 2026, possibly in no small part helped by a mutating virus that prompted WFH orders, with workers swapping out suits for styled up hoodies. Despite playing them at their own game - doubling their direct to consumer sales in 2021 - it seems Under Armour (UA) (UAA) joins an athleisure wear industry yet to knock premium power players Nike (NKE) and Lululemon (LULU) off the winners’ podium. 

While at 58-years-young Nike may enter the race as seniors, they’re high-jumping every other major sports label in China, despite Alibaba’s (BABA) play to enable questionable fake listings. Nike’s sales have more than doubled local sportswear brands Li Ning and Anta, who last year The Wall Street Journal hinted may yet sprint for victory. And it looks like investors sped ahead of Nike’s recent third quarter earnings reports, nudging their share price up 13.6% since mid-March, preceding Nike’s announcement of strong results despite their sliding market cap since November 2021.

What’s the secret sauce to Nike staying flavour of the month? 🍨 Nike’s iconic SB dunk collabs (like the Chunky Dunky)? Or their elite athlete’s LeBron James Innovation Center and sponsorships? Or is it their puzzling pivots, like France’s wealthiest football team Paris Saint-Germain swapping Nike’s swoosh for Jordan’s Jumpman, solidifying the club’s streetwear fashion-football (...to basketball?) status? Nike President and CEO John Donahoe puts their win down to their ‘deep consumer connections, compelling product innovation and an expanding digital advantage’, adding they’ve created ‘the right playbook to navigate volatility’.

Also vying for top medals, 24-year-old Gen Zer Lululemon reported strong revenue and profit in their fourth quarter, despite Omicron supply chains stretching the direct-to-consumer brand and warning of January staff shortages. Their flex? As well as upping the comfort factor in menswear, Lululemon this year tread into another stay-at-home staple, their Blissfeel sneakers. 👟 Are they coming after Allbirds (BIRD)? Perhaps fair after Allbirds have been breathing life into their own range of sustainable activewear. Battle lines drawn.

We’re not financial advisors and Hatch news is for your information only. However dazzling our writing, none of it is a recommendation to invest in any of the companies or funds mentioned. If you want support before making any investment decisions, consider seeking financial advice from a licensed provider. We’ve done our best to ensure all information is current when we pushed ‘publish’ on this article. And of course, with investing, your money isn’t guaranteed to grow and there’s always a risk you might lose money.

Join the Kiwis who are hatching their tomorrow and have invested more than $1 billion with Hatch.

Explore another series
Tax
Money
Economy
Investing

More recent news articles

Recent learn articles

8 min read
Mar 4, 2025

Can Biotech beat cancer?

Some Kiwi companies are making significant advances in cancer diagnosis and treatment that could save lives worldwide. Global pharmaceutical companies are also making huge strides in cancer clinical trials, but could Trump’s administration derail decades of research?
Read more
7 min read
Feb 12, 2025

Trump’s trade tariffs and the AI race

US President Trump has swept into the Oval Office proposing what some have called ‘punitive’ tariffs with its three largest trading partners, China, Canada and Mexico. But could tariffs plug America's massive deficit? And is there an even greater agenda to do with the trillion dollar AI race?
Read more
8 min read
Jan 21, 2025

2 Things Wall Street’s watching in 2025

2024 was a big year for AI, with Nvidia stocks soaring. Now what? Is it time for the return of IPOs? Some Wall Streeters have their eyes locked on potential 2025 high profile IPOs. And you’ve heard of ‘bits’, now could be the time to discover ‘qubits’ and how they could impact share markets in the long term.
Read more

Related news articles

More recent learn articles

No items found.

Recent news articles

More recent learn articles

8 min read
Mar 4, 2025

Can Biotech beat cancer?

Some Kiwi companies are making significant advances in cancer diagnosis and treatment that could save lives worldwide. Global pharmaceutical companies are also making huge strides in cancer clinical trials, but could Trump’s administration derail decades of research?
Read more
7 min read
Feb 12, 2025

Trump’s trade tariffs and the AI race

US President Trump has swept into the Oval Office proposing what some have called ‘punitive’ tariffs with its three largest trading partners, China, Canada and Mexico. But could tariffs plug America's massive deficit? And is there an even greater agenda to do with the trillion dollar AI race?
Read more
8 min read
Jan 21, 2025

2 Things Wall Street’s watching in 2025

2024 was a big year for AI, with Nvidia stocks soaring. Now what? Is it time for the return of IPOs? Some Wall Streeters have their eyes locked on potential 2025 high profile IPOs. And you’ve heard of ‘bits’, now could be the time to discover ‘qubits’ and how they could impact share markets in the long term.
Read more